Feed HAE
HA

Haemonetics HAE · NYSE

$118.76 +0.41% (+$0.48)

Market cap
$5.40B
Enterprise value
$6.35B
P/E
56.1x
Forward P/E
21.4x
PEG
0.8x
P/S
4.0x
P/FCF
18.6x
EV/EBITDA
24.3x
ROIC
8.6%
Bruto marža
57.4%
Neto marža
7.1%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
3.6x
Beta
0.54
Free float
98.7%

O podjetju

Haemonetics Corporation is an American company specializing in the development and manufacturing of medical technologies focused on blood product processing. Founded in 1971, the company’s primary focus is on innovations in blood transfusion, blood component separation, and patient monitoring. Haemonetics provides products and solutions for hospitals, blood banks, and transfusion centers that help optimize the processes of blood donation and usage, while ensuring safety and treatment efficiency. The company is known for its advanced devices and systems for separating plasma, red blood cells, and platelets, ensuring precision and quality in handling blood products.

Sector

Healthcare

Industry

Medical - Devices

CEO

Christopher A. Simon

Employees

3,009

Headquarters

Boston

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.